ResMed (ASX:RMD) acquired VirtuOx, a US-based diagnostic testing provider for sleep, respiratory, and cardiac conditions, according to a Thursday statement by the company.
Under the deal, VirtuOx will operate as the company's unit and offer its at-home diagnostic services, per the statement.
Financial terms of the deal were not disclosed, with the company stating the acquisition is not material to its financial results.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。